Meg Wirth is an expert in maternal and neonatal health innovation. She is the co-founder of Maternova and a S.E.VEN fellow and a Cartier Women's Initiative finalist. She has advised dozens of entrepreneurs and startups in women's health and global health. Meg has also worked as a member of the Rockefeller Foundation’s Health Equity team and co-edited a major volume called Challenging Inequities in Health: From Ethics to Action. She was a co-author of the UN Millennium Project’s final report on child and maternal health. She has a BA from Harvard University and an MPA in international development from Princeton University's Woodrow Wilson School. E-mail: email@example.com
Prakash brings over 15 years experience in leadership, strategy and project management. His background in the Navy has led him to wear several different hats including command of a warship, planning, and operations. He is an expert on sensor technology and has extensive expertise in international diplomacy, having worked with counterparts in North America, Europe, and Australia. Prior joining Maternova, Prakash worked with State Street Bank, MA in the strategic operations team. He holds an MBA from Babson College, Massachusetts.
Kevin Kennedy is Maternova's CFO along with acting as President of Double K Consulting Mr. Kennedy brings 20 years of experience having worked for and with a number of small businesses, trade associations, nonprofit organizations, and larger national and international corporations. The positions he has held include CFO, Treasurer, Director of Accounting, Director of Finance, Mergers & Acquisitions, Program Control Officer/Internal Auditor and Various Controllerships. E-mail: firstname.lastname@example.org
Atanur is a Business Analyst with Maternova. He develops market and customer evaluation models, criteria, and surveys, specializes in the top three Maternova products and develops customer relationships with large hospitals, humanitarian organizations and government Ministries. He has work experience with international trade, business development and end to end supply chain management.
Dr. Mallon works with Maternova as Director of Revenue & Growth, along with providing clinical expertise. He founded Calista Therapeutics in 2012 based upon the discovery and development of a technology platform of therapeutics that modulate the cellular transport, location, and activation of regulatory proteins. Dr. Mallon is a biotech entrepreneur, specializing in the identification and creation of early stage value in promising therapeutics in diseases that have high, unmet clinical need and de-risked development pathways.
Previously Dr. Mallon founded Ardane Therapeutics, Inc. (USA), and Carlton Pharmaceutics (UK). Dr. Mallon is an inventor on several patents based upon his discoveries in addition to several publications. Dr. Mallon has a Ph.D. from the University of Glasgow, taught and undertook research at Brown University and is a registered pharmacist. Dr. Mallon has served as an expert scientific reviewer for both the NIH and NSF grant committees focused upon drug development.